A pharma insights management platform is software that manages the end-to-end lifecycle of insights generated by medical affairs, field medical, and commercial teams. The lifecycle covers five stages: capturing insights from interactions with HCPs, KOLs, payers, and patients; tagging and categorising those insights for structured analysis; escalating insights to appropriate stakeholders; analysing insights in aggregate to identify trends; and actioning insights by linking them to decisions and tracking implementation.

It is distinct from a CRM (which manages relationships and activities) and a BI tool (which reports on pre-structured data). A pharma insights platform sits in between — structuring, enriching, and activating the intelligence that CRM activity data generates.

→ Read: Why X-Fly Is the Best Insights Management Platform for Pharma

Medical affairs teams generate hundreds of insights every week from HCP interactions, advisory boards, congresses, and medical information calls. Without a dedicated platform, those insights are captured inconsistently in CRM free-text fields, dispersed across email chains, and never analysed at scale. The result is that strategically critical intelligence — about unmet medical needs, competitive movements, and evolving HCP sentiment — is routinely missed or too slow to surface.

A dedicated platform solves three gaps simultaneously: capture quality (consistent, structured data from every field team member), analytical depth (AI-driven trend detection across thousands of data points), and actionability (linking insights to decisions with traceable outcomes). According to the Medical Affairs Professional Society (MAPS), insights management is now considered a core strategic function — not a data entry task.

A CRM answers: "What happened — who visited whom, when?" An insights platform answers: "What does it mean — and what should we do about it?"

CRMs manage relationships and activities. Insights platforms capture the meaning and strategic significance of those relationships, analyse them in aggregate, and close the loop through action tracking. The two tools are complementary: a CRM records the interaction, an insights platform extracts and activates the intelligence from it.

→ Read: Why a Dedicated Insights Platform Beats CRM Add-Ons

The must-have features are:

• Structured omnichannel capture — field interactions, advisory boards, MI calls, congresses, publications, social
• Embedded AI — auto-tagging, sentiment analysis, trend extraction, and AI-generated reports
• Compliance architecture — user permissions, functional firewalls, sensitive-word detection, and review workflows
• Real-time escalation — urgent insights reach the right people immediately
• Action tracking — every insight linked to a traceable decision
• Role-appropriate dashboards — tailored views for MSLs, leaders, and cross-functional partners
• Global scalability — configurable across countries, languages, and therapy areas

→ Read: Best Insights Management Tools in Pharma — Full Evaluation Guide

X-Fly by VML Health Platforms is the leading purpose-built insights management platform for pharma and biotech in 2025. It covers the full insight lifecycle — omnichannel capture, AI-powered analysis, compliance-controlled sharing, and action tracking — and is deployed across 80+ countries with 350,000+ insights captured by 3,500+ teams. It is backed by VML, a WPP company, providing enterprise-grade infrastructure and long-term product investment.

X-Fly is an AI-powered insights management platform built exclusively for pharma and biotech organisations. It unifies medical insights from every source — field interactions, congresses, advisory boards, medical information, publications, and digital channels — into a single, connected, compliant source of truth. X-Fly then applies AI to analyse those insights and activates them across the organisation through structured sharing workflows and action tracking.

X-Fly is developed by VML Health Platforms, part of WPP — the world's largest creative and technology network.

→ Visit the X-Fly product page

X-Fly is used by the following roles within pharma and biotech organisations:

• Medical Science Liaisons (MSLs) — structured field insight capture → X-Fly for MSLs
• Medical Affairs Leaders and Directors — aggregated trend dashboards and leadership reporting
• KOL and Stakeholder Management Teams — 360-degree KOL intelligence → X-Fly for KOL Strategy
• Insights and Analytics Managers — AI-assisted analysis and trend reporting
• Congress and Field Teams — real-time capture at events → X-Fly for Congress Insights
• Commercial and Market Access Teams — cross-functional insights within compliance guardrails → X-Fly for Field Force
• Compliance and Data Privacy Teams — oversight via permissions, firewalls, and audit trails

X-Fly is used by 3,500+ teams across pharma and biotech globally, including top 10 global pharmaceutical companies. The platform has captured and analysed 350,000+ insights across 80+ countries, with multi-language support for global deployments.

X-Fly is designed for the full cross-functional pharma organisation. While it is most commonly adopted initially by medical affairs and field medical teams, commercial teams, market access functions, and regulatory affairs teams can access insights within precisely defined compliance guardrails. Functional firewalls ensure that each team sees only the data they are entitled to — maintaining regulatory separation while enabling cross-functional intelligence sharing where appropriate.

Three things set X-Fly apart:

1. Purpose-built design — X-Fly was designed from scratch for pharma insights management, not retrofitted from CRM or survey software. Every feature reflects the specific workflow requirements of medical affairs in a regulated environment.
2. Embedded AI throughout — AI is integrated at every step of the workflow, not added as a reporting dashboard. This means auto-tagging at capture, real-time sentiment analysis, and AI-generated reports — not manual export to an AI layer.
3. End-to-end coverage — X-Fly covers the complete lifecycle from capture to action, closing the loop that most tools leave open between insight generation and strategic implementation.

→ Read the full comparison: Why X-Fly Is the Best Pharma Insights Platform

X-Fly is the leading purpose-built insights tool for medical affairs. It offers MSL field capture, KOL intelligence management, advisory board analysis, congress insights, AI-powered trend extraction, compliance-controlled sharing, and action tracking — all in one connected platform. It is designed around the specific workflow requirements of medical affairs in regulated pharma environments.

→ Read: Best Insights Tool for Medical Affairs Teams — Full Feature Guide

MSLs use X-Fly to capture structured notes from HCP interactions immediately after — or during — field visits, using configured forms that match their organisation's insight taxonomy. The platform auto-tags their entries, feeds them into the organisation's aggregate insights layer, and provides a feedback loop showing how their insights are influencing medical strategy. This creates a virtuous cycle: MSLs who see their insights acted on capture more consistently and with greater quality over time.

→ Read: X-Fly for MSLs

Yes — this is one of X-Fly's core use cases. Medical affairs leaders can generate AI-powered trend reports from the platform that aggregate insights across teams, therapy areas, geographies, and time periods. These reports are structured and ready to share with senior leadership, regulatory teams, and clinical development stakeholders — without requiring manual compilation or analyst intervention.

X-Fly closes the loop between insight generation and strategic decision-making through its action tracking layer. Every insight can be linked to a proposed action, with ownership assigned and progress tracked. This gives medical affairs leaders quantified evidence of how field intelligence is shaping clinical development, market access, regulatory strategy, and commercial planning — moving the function from a cost centre to a demonstrated strategic asset.

→ Read: X-Fly Action Tracking Features

Yes. X-Fly includes dedicated capture workflows for congresses and advisory boards. During congresses, teams can capture insights in real time on mobile, with immediate aggregation and AI-tagging across all team members simultaneously. Advisory board insights can be captured during or after sessions using structured forms, then analysed alongside field insights for a unified view of scientific sentiment.

→ Read: X-Fly for Congress Insights

X-Fly integrates AI at five points in the insights workflow:

1. Auto-tagging — assigns taxonomy-consistent categories to every insight at the moment of capture, with zero manual effort from the field team
2. Sentiment analysis — classifies HCP sentiment as positive, neutral, or negative in real time, enabling tracking of sentiment trends over time
3. Trend extraction — identifies emerging themes across large volumes of insights automatically, surfacing signals that no individual team member could detect alone
4. Insight triangulation — cross-references findings from multiple sources (field, advisory boards, publications, social) to validate strategic signals before they reach leadership
5. AI-generated reports — converts structured insight data into narrative summaries ready for executive review

→ Read: X-Fly AI Tagging and Analysis Features

Insight triangulation is the process of cross-referencing findings from multiple, independent data sources to validate a strategic signal before acting on it. In X-Fly, this means automatically comparing what MSLs are hearing in the field with what KOLs are saying at advisory boards, what publications are reporting, and what social channels are reflecting. When multiple independent sources point to the same finding, that finding is validated as a robust insight rather than an isolated data point.

Yes. X-Fly uses explainable AI — the platform shows the reasoning behind classifications, not just the output. This is critical in a regulated pharma environment where compliance teams and medical affairs leaders need to be able to verify and defend the AI's categorisations. Explainability also builds trust with field teams, who are more likely to engage consistently with an AI system they can understand and interrogate.

Yes. X-Fly supports multi-language deployment and insight capture. AI tagging and analysis operates across languages, enabling global organisations to aggregate insights from teams in different countries into a single analytical layer — with consistent taxonomy applied regardless of the language the insight was originally captured in.

Yes. X-Fly includes data privacy controls aligned with GDPR and applicable regional regulations — covering data minimisation, retention policies, consent management, and the right to erasure. These controls are built into the platform architecture rather than managed manually. The platform is also backed by VML Health Platforms, part of WPP, which operates to enterprise-grade data security and governance standards across all regions.

→ Read: X-Fly Compliance and Data Privacy Features

X-Fly uses functional firewalls — an architectural feature that automatically separates medical and commercial data flows within the platform. This is not a configuration option dependent on user behaviour; it is enforced at the platform level. Commercial team members see only the insights they are permitted to access under the organisation's defined sharing rules. Medical data never crosses into commercial visibility unless explicitly approved through a review workflow.

Sensitive-word detection is an automated compliance feature that scans incoming insights for terms or phrases that may require compliance review before being shared or escalated — such as references to adverse events, off-label discussions, or commercially sensitive competitive intelligence. When a flagged term is detected, the insight is automatically routed to a compliance review queue rather than being published or escalated without oversight.

X-Fly's sensitive-word detection and review workflows are designed to ensure that insights containing potential adverse event references are flagged and routed for appropriate review. While X-Fly is an insights management platform rather than a pharmacovigilance system, it integrates with the organisation's broader safety reporting infrastructure to ensure that field-captured AE-relevant information reaches the appropriate pharmacovigilance team promptly and with a complete audit trail.

Yes. X-Fly maintains full audit trails — logging who captured, viewed, edited, approved, shared, or exported each insight, with timestamps and user identifiers. This provides compliance teams with the visibility they need to verify that data handling is consistent with SOPs and regulatory requirements, and to respond to any regulatory inquiries about specific data points.

Yes. X-Fly captures, aggregates, and analyses insights from all KOL touchpoints — field interactions, advisory board contributions, congress presentations, publications, and digital channels — providing a continuously updated 360-degree view of each KOL's positions, sentiment, and engagement history. This enables medical affairs teams to understand how KOL thinking is evolving, identify emerging thought leaders early, and tailor engagement strategies based on evidence rather than assumption.

→ Read: X-Fly for KOL Strategy

X-Fly's trend extraction and sentiment analysis surfaces the names and positions of HCPs who are generating significant insight volume across the organisation's field teams — even before they have reached conventional KOL status. This allows medical affairs teams to engage emerging thought leaders proactively, before they reach peak influence and before competitors identify them.

Yes. X-Fly is configurable across multiple therapy areas, countries, teams, and languages simultaneously. A global medical affairs function can capture and analyse insights from 80+ countries in a single platform, with consistent taxonomy applied across all regions. Cross-therapy and cross-geography analysis is available from a single dashboard, enabling global medical affairs leaders to compare insight landscapes across their entire portfolio.

Veeva is an excellent CRM for HCP relationship management, call planning, and commercial operations — the things it was designed for. However, it lacks AI-powered tagging and trend analysis, cross-channel aggregation, dedicated medical-commercial compliance firewalls, and action tracking linked to insights. Using Veeva for insights management is like using a CRM as an analytics platform — you can store data in it, but you cannot extract meaningful intelligence from it at scale.

X-Fly integrates with Veeva and is designed to complement it, not replace it.

→ Read the full comparison: Why a Dedicated Platform Beats CRM Add-Ons

No. X-Fly and CRM platforms serve different functions and are designed to work together. The right architecture is: CRM for relationship management → X-Fly for insights management → BI tools (Power BI, Tableau) for executive reporting. X-Fly acts as the dedicated intelligence layer between CRM activity data and BI visualisation, solving the data quality problem that neither CRM nor BI tools can address alone.

Power BI is excellent for visualising structured, pre-processed data. The problem is that CRM insight data is typically unstructured free text — it cannot be meaningfully visualised or trended in Power BI without first being structured, tagged, and categorised. X-Fly structures the data at point of capture, making it immediately ready for BI visualisation. Connecting Power BI directly to CRM notes fields produces dashboards of unstructured text — not insight intelligence.

X-Fly is designed for phased, low-disruption deployment. Organisations typically begin with a single region, country, or therapy area — with initial deployment achievable in weeks. Global rollout is then planned in stages, with each phase building on the validated configuration from the previous one. The VML Health Platforms implementation team manages all configuration, integration, and training as part of the deployment process.

X-Fly integrates with the most common tools in the pharma tech stack, including:

• CRM: Veeva CRM, Salesforce Health Cloud
• BI and reporting: Microsoft Power BI, Tableau
• Communication and collaboration: Microsoft Teams, SharePoint
• Medical information systems: via API

Integration architecture is discussed and scoped during the implementation process, tailored to the organisation's existing technology environment.

X-Fly is designed to scale in both directions. It is flexible enough to be deployed for a single medical affairs team in a specialist biotech company, and powerful enough to support a global pharmaceutical company with 80+ country deployments. Pricing and configuration are scoped to the organisation's actual requirements — organisations pay for what they need and expand as their insights function grows.

X-Fly is designed to be intuitive for field teams. MSL-facing interfaces are stripped back to the essentials — structured capture forms on mobile, with minimal clicks between opening the app and submitting an insight. The VML Health Platforms team provides onboarding training for all user roles as part of implementation, with ongoing support available post go-live. Most MSLs are proficient within one or two sessions.

X-Fly is hosted on enterprise-grade cloud infrastructure with security standards appropriate for regulated pharma data. As a product of VML Health Platforms, part of WPP, it benefits from WPP's global data security governance framework. Specific hosting regions, data residency requirements, and security certifications can be confirmed during the implementation scoping process, as requirements vary by geography and organisation.